By overlapping the candidates from the radiation screens and the cisplatin screens in two NSCLC cells, we found BRD4 inhibitor JQ1, PI3KCA inhibitor Alpelisib, and BRD9 inhibitor I‐BRD9 that satisfy the criteria. The gene discussed is BRD4; the disease is non-small cell lung carcinoma.